News

Relistor is indicated as a treatment for opioid-induced constipation (OIC) in patients with chronic, non-cancer pain. The drug is currently approved in the US, Australia, European Union, Canada

Under the agreement, AMRI will combine its discovery and development capabilities with Proteros’ structural biology services to offer better services to the life sciences industry worldwide. Proteros is

Out of all licensed products, some are the US Food and Drug Administration (FDA) approved drugs while rest are unapproved. As per the terms of the agreement, Atley

In the study, the companies have randomized around 679 patients who are suffering from early-stage Parkinson’s disease. The companies will assess the safety and efficacy of two dose

The double blinded, placebo-controlled, single center and randomized trial aims to establish the dosage level of the vaccine while assessing the immugenicity and safety of EV71. The company

As per the terms of the amended agreement, Meda will be responsible to pay a sum of $45m to Medivir for transferring of all rights to the product

The current investment will ramp up the company’s R&D of multi-specific therapeutics. Eli Lilly intends to recruit biochemist and biologists to support its R&D for multi-specific drugs that

Stepan said the acquired product lines will be integrated into Stepan’s Food and Health Specialties business, which will be renamed Stepan Lipid Nutrition. Lipid Nutrition claims Clarinol conjugated

The FDA has also given permission for commencing Phase 1 trials with NRI-ANA as a treatment for an acute neuropathic pain condition using molecular skin penetration enhancers identified